MyAverix Finance
SHG · Healthcare
Bio-Thera Solutions Ltd (688177)
Biotechnology
Bio-Thera Solutions Ltd (688177) is listed on SHG in the Healthcare sector. Industry: Biotechnology. As of 2026-03-29, reported market cap is $9.23B, P/E ratio is 18.00, net margin is -36.0%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 688177
Bio-Thera Solutions Ltd (688177) — FAQ
What is Bio-Thera Solutions Ltd's market cap?
Bio-Thera Solutions Ltd (688177) has a reported market cap of $9.23B (data as of 2026-03-29).
What is 688177's P/E ratio?
The price-to-earnings (P/E) ratio for Bio-Thera Solutions Ltd (688177) is 18.00 (data as of 2026-03-29).
Does Bio-Thera Solutions Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Bio-Thera Solutions Ltd (688177). Check the MyAverix Finance app for the latest dividend data.
What sector is Bio-Thera Solutions Ltd in?
Bio-Thera Solutions Ltd (688177) is classified in the Healthcare sector (Biotechnology industry).
What exchange is 688177 listed on?
688177 is listed on SHG.
What is Bio-Thera Solutions Ltd's net margin?
Bio-Thera Solutions Ltd (688177) reports a net margin of -36.0% (data as of 2026-03-29).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.